New Analogues of Uridine as Possible Anti-Viral Agents Specific to SARS-CoV-2.

ABSTRACT: The development of specific drugs against SARS-CoV-2 infection is a major challenge facing global science and healthcare. Despite numerous attempts, there are still no truly effective drugs. Currently, the main approach in the creation of drugs against COVID-19 is repurposing, i.e., re-profiling existing drugs approved for medical use, for example, the use of a drug for the treatment of Ebola-Remdesivir, and the use of a drug for the treatment of influenza-Favipiravir. However, it is already obvious that these drugs are not specific enough nor effective enough. Another promising approach is the creation of new molecules, but it should be noted immediately that implementation requires much more time and costs. However, the search for new SARS-CoV-2 specific antiviral agents continues. The a

SUBMITTER: Maslova AA 

PROVIDER: S-EPMC9165921 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature